SCHEMBL18034496

SCHEMBL18034496

CC(CO)c1oc(=O)cc2c1[C@@H](O)C1OC(=O)[C@]3(C)C1[C@]2(C)CC[C@@H]3O

nearest known ligand 0.69

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.69
▸ HTT P42858 2/20 0.69
▸ SMN1; SMN2 Q16637 2/20 0.69
▸ POLB P06746 1/20 0.69
▸ NPC1 O15118 1/20 0.56
▸ MITF O75030 1/20 0.56
▸ NFKB1 P19838 1/20 0.56
▸ RAB9A P51151 1/20 0.56
▸ NFKB2 Q00653 1/20 0.56
▸ RELA Q04206 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18034638 0.90 LMNA (0.84) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL18034515 0.90 LMNA (0.84) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL18034495 0.82 LMNA (0.60) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL29709886 0.82 LMNA (1.00) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL18034516 0.82 LMNA (1.00) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL29709820 0.76 LMNA (0.84) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL18034494 0.75 LMNA (0.74) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL29709864 0.71 LMNA (1.00) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL18290307 0.71 LMNA (1.00) LMNAHTTSMN1; SMN2POLBNPC1
SCHEMBL18034509 0.71 LMNA (0.74) LMNAHTTSMN1; SMN2POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016131426-A1 NAGILACTONE COMPOUNDS HAVING ANTILIPEMIC ACTIVITY, PREPARATION METHOD THEREFOR AND USES THEREOF 中国科学院上海药物研究所 2016-08-25 — — WO disclosed
Send feedback